How biomarkers are changing cancer care
(Thursday Feb 3 @ 7am NZT) Wednesday, February 2, at 1:00 p.m. ET / 10:00 a.m. PT
Biomarkers, including genetic alterations in tumor cells and even pieces of DNA that can be detected in the blood, are changing the way that doctors treat cancer. A look at some of the latest technological advances.
Speakers:Anna D. Barker, Ph.D., chief strategy officer, Ellison Institute for Transformative Medicine of USC; distinguished visiting fellow, complex systems, Arizona State UniversityGeorge Demetri, director of the Sarcoma Center at Dana-Farber, director of the Ludwig Center at Dana-Farber/Harvard Cancer Center, and executive director for Clinical and Translational Research at the Ludwig Institute for Cancer ResearchSuzanne Topalian, professor of surgery and oncology at the Johns Hopkins University School of Medicine; associate director of the Bloomberg-Kimmel Institute for Cancer ImmunotherapyMatthew Herper, senior writer, medicine; editorial director of events, STAT (moderator)Josina Reddy, MD, PhD, global head and vice president of product development for lung, agnostic, skin, rare cancers at Genentech (sponsor speaker)